Improving Patient Compliance in Acne Trials

AWARD:  $15,000 USD
DEADLINE: Mar 30 2017 23:59 EDT
POSTED: Feb 28 2017
SOURCE: InnoCentive

In clinical trials, patient compliance with taking/applying medication is extremely important. In Acne vulgaris trials, medication is typically applied 1 or 2 times a day over an extended period (e.g., ~12 weeks) which may make 100% compliance difficult to achieve. The Seeker is looking for ideas/methods to improve compliance in acne trials.

This Theoretical Challenge requires only a written proposal.

Challenge ID: 9933945
Team Project Rooms are available on this Challenge. Team Share Challenge Share
Challenge Overview

High levels of patient compliance are very important in clinical trials in order to efficiently detect true drug efficacy and safety, particularly for indications such as acne vulgaris.  In clinical trials of medicine to treat acne vulgaris, it is very difficult to achieve 100% patient compliance for various reasons such as the long duration of the trials. Across indications and clinical settings, many techniques have been tried to increase patient compliance with medications (e.g. electronic messaging, alarms, diaries, incentives) but there is no consistent, proven method which would be applicable to clinical trials of medicine to treat acne vulgaris. Ideas and methods are being solicited to improve compliance for all genders and teenagers as well as adults when applying medicine daily for 12 weeks. Your submission should make specific recommendations and be backed by sound reasoning/data.

This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. If multiple proposals meet all the Solution Requirements, the Seeker reserves the right to award only the solution which they believe is superior and cost effective. 

To receive an award, the Solvers will have to transfer to the Seeker their exclusive Intellectual Property (IP) rights to the solution.

Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on March 30, 2017.

Late submissions will not be considered.

What is InnoCentive?

InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.

What is a Theoretical IP Transfer Challenge?

An InnoCentive Theoretical Challenge builds upon an idea but is not yet a proof of concept. A solution to a Theoretical Challenge will solidify the Solver's concept with detailed descriptions, specifications and requirements necessary to bringing a good idea closer to becoming an actual product or service.

This Challenge is a Theoretical-IP Transfer Challenge, meaning that Solvers must relinquish all rights to the Intellectual Property (IP) for which they are awarded. By contrast, Theoretical-Licensing means that the Seeker is requesting non-exclusive rights to use the winning solution. For these forms of a Theoretical Challenge, Solvers that do not win retain the rights to their solution after the evaluation period is complete. The Seeker retains no rights to any IP not awarded.

Share This Challenge
Challenge Data (What's This?)
Solver Map
Solver Map
InnoCentive Trust Partners